- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Milk outperforms barium as GI contrast medium
Barium simply cannot compete with milk in cost or taste when it comes to contrast- enhanced CT of the gastrointestinal tract, according to Columbia University researchers.
Barium simply cannot compete with milk in cost or taste when it comes to contrast-
enhanced CT of the gastrointestinal tract, according to Columbia University researchers.
Radiologist Dr. Chi Wan Koo and colleagues enrolled 215 consecutive patients scheduled for abdominal and pelvic CT. One hundred received a 0.1% barium suspension, and 115 were given whole milk. Researchers compared visibility and costs for the two enhancing techniques and asked patients about their tolerance of either oral contrast agent. The investigators found that images from patients who drank milk were just as clinically useful as those from patients who received the barium suspension. Milk was also less expensive ($1.48 versus $18 per dose) and had better patient acceptance and fewer adverse symptoms.
The researchers published their findings in the American Journal of Roentgenology (2008;190:1307-1313).
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
